BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 27451857)

  • 1. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
    Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
    Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, crystal structure and biological evaluation of substituted quinazolinone benzoates as novel antituberculosis agents targeting acetohydroxyacid synthase.
    Lu W; Baig IA; Sun HJ; Cui CJ; Guo R; Jung IP; Wang D; Dong M; Yoon MY; Wang JG
    Eur J Med Chem; 2015 Apr; 94():298-305. PubMed ID: 25771108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
    Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
    J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, characterization and evaluation of potent inhibitors of Shigella sonnei acetohydroxyacid synthase catalytic subunit.
    Lim WM; Baig IJ; La IJ; Choi JD; Kim DE; Kim SK; Hyun JW; Kim G; Kang CH; Kim YJ; Yoon MY
    Biochim Biophys Acta; 2011 Dec; 1814(12):1825-31. PubMed ID: 22015678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of inhibitors of Haemophilus influenzae acetohydroxyacid synthase.
    Gedi V; Moon JY; Lim WM; Lee MY; Lee SC; Koo BS; Govindwar S; Yoon MY
    Enzyme Microb Technol; 2011 Jun; 49(1):1-5. PubMed ID: 22112263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evaluation of residues in the herbicide-binding site of Mycobacterium tuberculosis acetohydroxyacid synthase by site-directed mutagenesis.
    Jung IP; Cho JH; Koo BS; Yoon MY
    Enzyme Microb Technol; 2015 Oct; 78():18-26. PubMed ID: 26215340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library.
    Choi KJ; Yu YG; Hahn HG; Choi JD; Yoon MY
    FEBS Lett; 2005 Aug; 579(21):4903-10. PubMed ID: 16111681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.
    Cho JH; Lee MY; Baig IA; Ha NR; Kim J; Yoon MY
    Biochimie; 2013 Jul; 95(7):1411-21. PubMed ID: 23523771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China.
    Dong M; Wang D; Jiang Y; Zhao L; Yang C; Wu C
    Saudi Med J; 2011 Nov; 32(11):1122-6. PubMed ID: 22057598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of bacterial acetohydroxyacid synthase (AHAS) and specific inhibitors of Mycobacterium tuberculosis AHAS as potential drug candidates against tuberculosis.
    Gokhale K; Tilak B
    Curr Drug Targets; 2015; 16(7):689-99. PubMed ID: 25882218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro and intracellular efficacy of new monosubstituted sulfonylureas against extensively drug-resistant tuberculosis.
    Wang D; Pan L; Cao G; Lei H; Meng X; He J; Dong M; Li Z; Liu Z
    Int J Antimicrob Agents; 2012 Nov; 40(5):463-6. PubMed ID: 22867883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of inhibitors against Mycobacterium tuberculosis thiamin phosphate synthase, an important target for the development of anti-TB drugs.
    Khare G; Kar R; Tyagi AK
    PLoS One; 2011; 6(7):e22441. PubMed ID: 21818324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.